A Study Of Glasdegib In Healthy Volunteers To Establish The Bioequivalence Of The Phase 2 Formulation To The ICH Formulation
Clinical trial NCT03130556 · COMPLETED
Trial details
- NCT number
- NCT03130556
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2017-07-06
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.